Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
1,624.50
-51.45 (-3.07%)
BSENSE

Oct 09

BSE+NSE Vol: 41.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
13.37
13.37
13.37
13.37
13.37
12.34
Share Warrants & Outstandings
Total Reserve
650.38
547.58
474.18
446.97
427.08
374.19
Shareholder's Funds
663.75
560.95
487.55
460.34
440.45
400.28
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
38.68
38.68
38.68
46.83
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.09
Unsecured Loans
0.00
0.00
38.68
38.68
38.68
46.74
Deferred Tax Assets / Liabilities
14.34
15.58
10.92
10.65
-0.68
3.63
Other Long Term Liabilities
11.05
0
0
0
0
0.28
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.81
2.90
10.26
8.85
7.95
7.38
Total Non-Current Liabilities
28.20
18.48
59.86
58.17
45.95
58.12
Current Liabilities
Trade Payables
113.49
91.86
53.18
50.84
50.17
71.36
Other Current Liabilities
43.95
36.65
22.53
27.23
37.66
20.92
Short Term Borrowings
0.00
1.69
2.65
3.61
4.17
4.49
Short Term Provisions
4.32
6.08
1.05
0.89
0.75
0.68
Total Current Liabilities
161.76
136.29
79.42
82.57
92.74
97.44
Total Liabilities
853.70
715.72
626.82
601.08
579.14
555.85
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
632.05
636.80
614.93
603.75
612.50
616.32
Less: Accumulated Depreciation
412.64
407.38
396.40
387.78
371.57
354.63
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
219.41
229.42
218.53
215.96
240.94
261.68
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
51.36
26.39
21.08
26.10
25.23
25.11
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
163.82
54.82
0.02
0.00
0.00
0.00
Long Term Loans & Advances
6.82
4.97
23.16
33.95
33.36
33.74
Other Non Current Assets
4.91
3.21
4.50
2.23
1.57
1.29
Total Non-Current Assets
458.50
318.81
267.30
278.25
301.10
321.82
Current Assets Loans & Advances
Current Investments
73.80
29.28
19.09
20.13
0.00
0.00
Inventories
129.37
100.49
121.69
119.94
125.64
119.99
Sundry Debtors
103.28
112.22
80.50
76.66
38.60
32.04
Cash and Bank
29.61
80.10
68.09
54.45
50.40
31.42
Other Current Assets
11.84
12.59
31.30
31.53
33.52
34.42
Short Term Loans and Advances
47.32
62.22
38.85
20.12
29.88
16.16
Total Current Assets
395.20
396.92
359.52
322.83
278.04
234.03
Net Current Assets (Including Current Investments)
233.45
260.63
280.11
240.26
185.30
136.59
Total Current Assets Excluding Current Investments
321.40
367.63
340.44
302.70
278.04
234.03
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
853.70
715.72
626.82
601.08
579.14
555.85
Contingent Liabilities
19.86
38.20
37.39
39.60
10.63
0.16
Total Debt
0.00
1.69
41.33
42.29
42.84
51.32
Book Value per share (adjusted)
496.56
419.65
364.74
344.38
329.5
313.18
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is -100.00% vs -95.91% in Mar 2025

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 5.85% vs 6.76% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 198.83% vs 2,74,000.00% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is -0.43% vs 10.40% in Mar 2025

Compare Balance Sheet Results of Venus Remedies
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.37
94.00
-80.63
-85.78%
Share Warrants & Outstandings
Total Reserve
650.38
320.99
329.39
102.62%
Shareholder's Funds
663.75
414.99
248.76
59.94%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
14.34
8.12
6.22
76.60%
Other Long Term Liabilities
11.05
1.59
9.46
594.97%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.81
5.41
-2.60
-48.06%
Total Non-Current Liabilities
28.20
15.13
13.07
86.38%
Current Liabilities
Trade Payables
113.49
74.39
39.10
52.56%
Other Current Liabilities
43.95
21.44
22.51
104.99%
Short Term Borrowings
0.00
1.47
-1.47
-100.00%
Short Term Provisions
4.32
6.42
-2.10
-32.71%
Total Current Liabilities
161.76
103.73
58.03
55.94%
Total Liabilities
853.70
533.85
319.85
59.91%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
632.05
157.06
474.99
302.43%
Less: Accumulated Depreciation
412.64
66.90
345.74
516.80%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
219.41
90.16
129.25
143.36%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
51.36
0.00
51.36
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
163.82
95.88
67.94
70.86%
Long Term Loans & Advances
6.82
1.79
5.03
281.01%
Other Non Current Assets
4.91
15.64
-10.73
-68.61%
Total Non-Current Assets
458.50
203.48
255.02
125.33%
Current Assets Loans & Advances
Current Investments
73.80
106.52
-32.72
-30.72%
Inventories
129.37
62.88
66.49
105.74%
Sundry Debtors
103.28
110.50
-7.22
-6.53%
Cash and Bank
29.61
6.34
23.27
367.03%
Other Current Assets
11.84
32.63
-20.79
-63.71%
Short Term Loans and Advances
47.32
11.50
35.82
311.48%
Total Current Assets
395.20
330.37
64.83
19.62%
Net Current Assets (Including Current Investments)
233.45
226.64
6.81
3.00%
Total Current Assets Excluding Current Investments
321.40
223.85
97.55
43.58%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
853.70
533.85
319.85
59.91%
Contingent Liabilities
19.86
0.78
19.08
2,446.15%
Total Debt
0.00
1.47
-1.47
-100.00%
Book Value per share (adjusted)
496.56
4.41
492.15
11,159.86%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -100.00% vs -95.91% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 11.05 Cr
in Mar 2026

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 270.77 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.85% vs 6.76% in Mar 2025

Annual - Investments
Investments 163.82 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 198.83% vs 2,74,000.00% in Mar 2025

Annual - Current Assets
Current Assets 395.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.43% vs 10.40% in Mar 2025